Advocating for Children with Cancer: Proposed Revision of European Pharmaceutical Legislation

“The European Commission proposed the revision of the European pharmaceutical legislation in April. After years of advocating for children with cancer, we want to highlight 4 key points that can make an important difference. This week, Delphine Heenen talks about a big leap forward: the recognition that new cancer drugs developed for adults can be useful for young patients too in a different type of cancer and the obligation to have those drugs tested in children.”

Source: KickCancer/Linkedin